Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300.
about
Development of polymeric micelles for targeting intractable cancersAdvances in drug delivery system for platinum agents based combination therapyNanoparticles Effectively Target Rapamycin Delivery to Sites of Experimental Aortic Aneurysm in RatsCore-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical TranslationEnhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivoUtility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect.Therapeutic nanoparticles in clinics and under clinical evaluation.The drug discovery by nanomedicine and its clinical experience.Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations.Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug DeliveryPolypeptide-Based Conjugates as Therapeutics: Opportunities and Challenges.Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.NC-6300, an epirubicin-incorporating micelle, extends the antitumor effect and reduces the cardiotoxicity of epirubicin.Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization"P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.Polymeric micelles for targeted tumor therapy of platinum anticancer drugs.A first-in-human Phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors.Stimuli responsive polymer-based strategies for polynucleotide delivery
P2860
Q26749611-866C86F1-5C46-4651-AAE7-1A34DFA8F899Q26771390-1569A6E1-9013-4EA9-883B-B9AAF8A0CD13Q28552112-78852896-D7ED-4A36-B6CF-3AAFFAE3E939Q35438759-F307F0BF-5FBA-40D5-B5C7-809B5F4818A1Q35674222-58C1B369-C1EB-48DA-B0D9-A770CA3242CBQ36058744-CAB41D64-ED7E-4B3B-9D1E-E31BB188CD9FQ36746313-EAFC755B-6264-418E-B33B-9D264FBA4B1AQ38087986-EF45B49F-FCCA-4677-9FCE-69891F8C6456Q38206349-F8C03F9E-EDF2-4DB9-9C8F-5F37C9ED60FAQ38709654-E0741A36-6562-48EB-8D75-BD6B0F7EC3ABQ38800427-5195731D-5715-4C64-B82E-8B7D15C11FAEQ38896198-798932C0-6B69-4673-83A1-0DFF5264AA7BQ38983708-D0A871D6-DE1F-46CD-9B22-8E840FFC3EF6Q39041944-9B14D388-5648-4CFE-972A-2B5639F95E2DQ39180778-EA5ED022-047A-4C9C-A5C0-F21A3B01D4E8Q42708764-1DDE1E71-8C55-495B-BBFF-D07EABC5C19FQ48324019-7CC28991-AEB3-4214-9A6A-D04E6E4D4388Q50960383-7CBE7748-7F8B-4F68-82BB-6F15D185E9FAQ53593680-AED3A312-902A-489B-ACD8-0B3B038AD9E0Q57371723-9741FD29-3D77-4889-90B1-21AE5706056A
P2860
Improved anti-tumor activity of stabilized anthracycline polymeric micelle formulation, NC-6300.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@en
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@nl
type
label
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@en
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@nl
prefLabel
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@en
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@nl
P2093
P1433
P1476
Improved anti-tumor activity o ...... micelle formulation, NC-6300.
@en
P2093
Hiroyuki Saito
Iulian Bobe
Mitsunori Harada
Naoya Shibata
Ryosuke Tanaka
Tatsuyuki Hayashi
Yasuki Kato
P2860
P304
P356
10.1111/J.1349-7006.2010.01745.X
P577
2010-10-06T00:00:00Z